Outcomes Network Graph
Outcomes Flow Chart
Treatment Effectiveness
User reported effectiveness ratings Xanax for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Crohn's Disease | 14% | 29% | 14% | 43% | 0% | 14 |
| Depression | 12% | 46% | 6% | 29% | 7% | 211 |
| Fibromyalgia | 9% | 33% | 13% | 36% | 8% | 108 |
| Irritable Bowel Syndrome | 0% | 31% | 4% | 59% | 6% | 49 |
| Migraine | 0% | 67% | 0% | 33% | 0% | 3 |
| Multiple Sclerosis | 17% | 33% | 6% | 39% | 6% | 18 |
| PTSD | 22% | 37% | 11% | 22% | 9% | 46 |
| Restless Legs Syndrome | 12% | 35% | 0% | 47% | 6% | 17 |
| Social Anxiety Disorder | 17% | 42% | 17% | 8% | 17% | 12 |
| Eating Disorders | 13% | 47% | 0% | 33% | 7% | 15 |
Side Effects
User-reported side effects of Xanax
| Side Effect | Percent of Reports Xanax |
|---|---|
| Irritability | 16% |
| Suicidal Thoughts | 6% |
| Constipation | 13% |
| Depression | 23% |
| Dry Mouth | 23% |
| Blurred Vision | 13% |
| Confusion | 28% |
| Convulsion | 1% |
| Decreased Alertness and Concentration | 57% |
| Decreased Appetite | 15% |
| Decreased Inhibitions | 40% |
| Decreased Sex Drive | 24% |
| Difficulty Controlling Impulses | 15% |
| Dizziness | 26% |
| Drowsiness | 62% |
| Forgetfulness | 36% |
| High Blood Pressure | 8% |
| Hot Flashes When Dosage Increased | 2% |
| Hyperactivity | 7% |
| Increased Appetite | 19% |
| Jaundice | 2% |
| Light-Headedness | 28% |
| Muscle Weakness | 11% |
| Nightmares | 20% |
| Racing Thoughts | 11% |
| Reduced Anxiety | 86% |
| Reduced Panic | 80% |
| Seizure | 1% |
| Tremor | 6% |
| Vomiting | 2% |
| Watery Mouth | 1% |
| Fatigue | 54% |
| Insomnia | 12% |
| Nausea | 8% |
Outcomes
Below is the degree of change seen after Xanax is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Xanax Info
| Property | Value |
|---|---|
| Variable Name | Xanax |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-09-15 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 34.644769239514 |
| Mean | 0.35572399038462 milligrams |
| Median | 0.1875 milligrams |
| Minimum Allowed Value | 0 milligrams |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 52 |
| Number of Measurements | 770 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 761 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0.26908869702398 |
| Unit | Milligrams |
| User Variables | 9 |
| UPC | 643307990577 |
| Variable Category | Treatments |
| Variable ID | 1490 |
| Variance | 0.12462469668151 |